These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 23912174)

  • 1. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats.
    Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T
    Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
    Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
    Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats.
    Ishikane S; Yamahara K; Sada M; Harada K; Kodama M; Ishibashi-Ueda H; Hayakawa K; Mishima K; Iwasaki K; Fujiwara M; Kangawa K; Ikeda T
    J Mol Cell Cardiol; 2010 Nov; 49(5):753-61. PubMed ID: 20692268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
    Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction.
    Hu X; Wang J; Chen J; Luo R; He A; Xie X; Li J
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):438-43. PubMed ID: 17239611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.
    Tang YL; Zhao Q; Qin X; Shen L; Cheng L; Ge J; Phillips MI
    Ann Thorac Surg; 2005 Jul; 80(1):229-36; discussion 236-7. PubMed ID: 15975372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat.
    Mazo M; Gavira JJ; Abizanda G; Moreno C; Ecay M; Soriano M; Aranda P; Collantes M; Alegría E; Merino J; Peñuelas I; García Verdugo JM; Pelacho B; Prósper F
    Cell Transplant; 2010; 19(3):313-28. PubMed ID: 19919732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction.
    Wang CC; Chen CH; Lin WW; Hwang SM; Hsieh PC; Lai PH; Yeh YC; Chang Y; Sung HW
    Cardiovasc Res; 2008 Feb; 77(3):515-24. PubMed ID: 18006453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis.
    Tsuda H; Yamahara K; Ishikane S; Otani K; Nakamura A; Sawai K; Ichimaru N; Sada M; Taguchi A; Hosoda H; Tsuji M; Kawachi H; Horio M; Isaka Y; Kangawa K; Takahara S; Ikeda T
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1004-13. PubMed ID: 20739390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair.
    Zhang D; Zhang F; Zhang Y; Gao X; Li C; Yang N; Cao K
    Transpl Int; 2007 Feb; 20(2):174-83. PubMed ID: 17239026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
    Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
    Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model.
    Wang W; Jiang Q; Zhang H; Jin P; Yuan X; Wei Y; Hu S
    Regen Med; 2011 Mar; 6(2):179-90. PubMed ID: 21391852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction.
    Du YY; Zhou SH; Zhou T; Su H; Pan HW; Du WH; Liu B; Liu QM
    Cytotherapy; 2008; 10(5):469-78. PubMed ID: 18608353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
    Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.